NewGenIvf Group Limited (NIVF)
- Previous Close
3.7700 - Open
3.5300 - Bid 2.6000 x 200
- Ask 3.7100 x 200
- Day's Range
2.8200 - 3.6800 - 52 Week Range
1.0900 - 32.8000 - Volume
257,028 - Avg. Volume
488,458 - Market Cap (intraday)
2.267M - Beta (5Y Monthly) 0.25
- PE Ratio (TTM)
-- - EPS (TTM)
-293.1000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company's services include mitochondrial replacement (MRT) therapy in reproductive, intrauterine insemination, MRT techniques, intracytoplasmic sperm injection, semen analysis, testicular sperm extraction/testicular sperm aspiration/PESA, egg freezing, and chromosome screening. It also provides in vitro fertilization (IVF) treatment; surrogacy and ancillary caring services, including regular body check, as well as provision of vitamins, supplements, and medicines to surrogate mothers; and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company offers its services through its clinics. The company was founded in 2010 and is based in Central, Hong Kong.
newgenivf.com76
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NIVF
View MorePerformance Overview: NIVF
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NIVF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NIVF
View MoreValuation Measures
Market Cap
2.83M
Enterprise Value
5.40M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.00
Price/Book (mrq)
--
Enterprise Value/Revenue
0.99
Enterprise Value/EBITDA
224.07
Financial Highlights
Profitability and Income Statement
Profit Margin
-9.66%
Return on Assets (ttm)
-17.99%
Return on Equity (ttm)
-53.76%
Revenue (ttm)
5.43M
Net Income Avi to Common (ttm)
-524.64k
Diluted EPS (ttm)
-293.1000
Balance Sheet and Cash Flow
Total Cash (mrq)
1.53M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
547.93k